Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Neville Hartley
 -- 1899 2022-04-18 12:18:08 |
2 format corrected.
Beatrix Zheng
 Meta information modification 1899 2022-04-19 04:39:54 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Hartley, N.; Mclachlan, C. Aromas Influencing the GABAergic System. Encyclopedia. Available online: https://encyclopedia.pub/entry/21880 (accessed on 15 November 2024).
Hartley N, Mclachlan C. Aromas Influencing the GABAergic System. Encyclopedia. Available at: https://encyclopedia.pub/entry/21880. Accessed November 15, 2024.
Hartley, Neville, Craig Mclachlan. "Aromas Influencing the GABAergic System" Encyclopedia, https://encyclopedia.pub/entry/21880 (accessed November 15, 2024).
Hartley, N., & Mclachlan, C. (2022, April 18). Aromas Influencing the GABAergic System. In Encyclopedia. https://encyclopedia.pub/entry/21880
Hartley, Neville and Craig Mclachlan. "Aromas Influencing the GABAergic System." Encyclopedia. Web. 18 April, 2022.
Aromas Influencing the GABAergic System
Edit
This entry is adapted from the peer-reviewed paper 10.3390/molecules27082414

Aromas have a powerful influence in people's everyday life and are known to exhibit an array of pharmacological properties, including anxiolytic, anti-stress, relaxing, and sedative effects. Numerous animal and human studies support the use of aromas and their constituents to reduce anxiety-related symptoms and/or behaviours. Although the exact mechanism of how these aromas exert their anxiolytic effects is not fully understood, the GABAergic system is thought to be primarily involved. The fragrance emitted from a number of plant essential oils has shown promise in recent studies in modulating GABAergic neurotransmission, with GABAA receptors being the primary therapeutic target. 

aromas essential oils volatile chemicals constituents GABAergic GABAA receptor anxiolytic sedative

1. Introduction

The sense of smell with aromas is common in everyday life, and these aromas can elicit neurological, cognitive, or behavioural responses [1]. For example, it is not uncommon for a smell to evoke a previous visual memory [2]. Aromatic plants and oils have been used as incense, perfumes and cosmetics, for medicinal and culinary purposes, and in religious rituals since time immemorial. Sprigs of juniper are still burnt in Tibetan temples in the East for purification, as are frankincense used during Roman Catholic mass in the West [3] (p. 11).
In recent times, studies have revealed inhalation of certain aromas exerts psychophysiological effects on humans [4]. Numerous animal and human studies have demonstrated anti-anxiety effects from the inhalation of various aromas [5][6][7] and other studies have elucidated the purported mechanism of action of these aromas exerting their anxiolytic effects [1].
Aromas are volatile chemicals < 300 Da that are detected by the olfactory system [4]. Aromas first dissolve into the mucus lining of the nasal cavity and then bind to olfactory receptors in the olfactory epithelium, generating an action potential within the receptor neuron [2][4]. An electrical signal is created and sent to the olfactory bulb for primary processing and then for final processing in various brain regions such as the amygdala, hippocampus, orbitofrontal cortex, and thalamus [2]. The olfactory neuroanatomy is intertwined with the primary emotional areas, including the amygdala, hippocampus, and orbitofrontal cortex via extensive reciprocal axonal connections [7]. It is also thought that these aromas may exert direct effects on neuronal receptors in the brain by crossing the blood-brain barrier [4].
The brain regions most crucial in regulating negative emotions such as anxiety are a set of limbic structures with the amygdala being a focal point [8]. A common finding from a variety of clinical anxiety disorders including social anxiety disorder, post-traumatic stress disorder (PTSD), obsessive compulsive disorder, phobias, and panic disorder is hyperactivity of the amygdala in response to negatively valanced stimuli [9]. Of particular interest is the brain GABAergic system, which is central to the regulation of anxiety. γ-aminobutyric acid (GABA) is a major inhibitory neurotransmitter in the central nervous system (CNS) and is said to be utilised by one-third of CNS neurons as their primary neurotransmitter [8]. GABAergic neurotransmission in the amygdala is important in regulating anxiety-related behaviours [8]. For instance, administration of benzodiazepines reduces amygdala activation in the presence of negative emotional stimuli. In addition, infusions of GABA or GABA receptor agonists into the amygdala decreases measures of anxiety in several animal species [8]. The hippocampus is another limbic structure that has reciprocal connections with the amygdala, projects to the hypothalamus affecting the release of adrenocorticotropic hormones, and has been implicated in dementia [10], anxiety disorders, and PTSD [11]. Animal studies using dementia models have revealed early loss of GABAergic interneurons resulting in hippocampal hyper-excitability, and neuroimaging studies in patients with dementia have reported hyper activity in the hippocampus [12]. Many dementia patients experience high levels of anxiety. In addition, several molecular and biochemical changes in the GABAergic system have been reported in the dementia brain, in particular a reduced expression of GABAA receptors in hippocampal neurons [13]. Thus, the GABAergic system undergoes significant remodelling in the dementia brain, and administration of exogenous agents that bind to GABA receptors may prove a useful tool in inhibiting typical GABA-related phenotypes, such as anxiety [14].
Neuronal inhibition of GABA is mediated via GABA receptors with GABAA receptors being important in controlling excitability of the brain and modulating anxiety [15]. GABAA receptors are a superfamily of pentameric ligand-gated ion channels that are widely distributed in the brain [15], consisting of five subunits arranged pseudo-symmetrically around a central pore with each subunit comprising of an extracellular, intracellular, and transmembrane domain [16]. The five subunits are made up of two α, two β, and one γ subunit, typically γ2, as approximately 75–80% of all GABAA receptors contain γ2 [17]. Each one of the subunits has a distinct cellular and reginal distribution in the brain with some cell types expressing few, most, or all GABAA receptor subunits [15]. Two binding pockets for GABA in GABAA receptors are formed at the extracellular interface between adjacent α and β subunits. The pockets are formed by loops A-C of the β subunit at the principle side and loops D-F of the α subunit at the complementary side [15]. Benzodiazepines are a class of anxiolytic compounds that bind to GABAA receptors at the interface between adjacent α and γ2 subunits enhancing flux of GABA-induced chloride ions, resulting in neuronal hyperpolarization and allosteric modulation of these receptors [15][17]. GABAA receptors are chloride ion channels that open in response to GABA and are influenced via medications such as benzodiazepines, barbiturates, and, more recently, via inhaling certain aromatic compounds.

2. Current Insights

The use of aromatic plants and oils for medicinal purposes is well established, and it is clear from the literature that aromas have known psychophysiological effects within areas of the brain associated with stress and anxiety modulation. The brain regions most crucial in regulating anxiety are a set of limbic structures, including the amygdala and hippocampus, which are intertwined and intimately connected with the olfactory neuroanatomy via extensive reciprocal axonal connections [7][8]. The amygdala and hippocampus are commonly associated in anxiety disorders, PTSD, and dementia [9][10][11]. Studies have supported the role of GABAergic neurotransmission in the amygdala in regulating anxiety-related behaviours [8]. The hippocampus has reciprocal connections with the amygdala, projects to the hypothalamus affecting the release of adrenocorticotropic hormones [10], and has been associated with significant remodeling of the GABAergic system in the dementia brain where hippocampal neurons have reduced expression of GABAA receptors [12]. Neuronal inhibition of GABA is mediated via GABA receptors with GABAA receptors at the forefront in controlling excitability of the brain and modulating anxiety [15]. The use of exogenous agents that bind to GABA receptors may prove a useful tool in inhibiting typical GABA-related phenotypes, such as anxiety [14].
Aromas found in common beverages, food, spices, volatile organic compounds, popular botanicals, and their constituents were reviewed for their anxiety reducing and sedative properties acting upon the GABAergic system. Numerous animal and human studies have confirmed anxiolytic and sedative effects from the inhalation of essential oils and or aromatic compounds [5][6][18][19]; however, only few have directly examined the effect on GABAA receptors. The aromas shown to potentiate a GABAA receptor response were lavender, whisky fragrance, and aged whiskey. Studies, however, have shown that oral administration of agarwood essential oil potentiating GABAA receptor function and regulating GABAA receptor gene expression [20] and aqueous coffee extract and coffee components elicited a GABAA receptor response in Xenopus oocytes [21]. Despite the lack of direct studies on GABAA receptors, some of the main chemical constituents present in the essential oils and/or aromatic compounds have been evaluated for their GABAA receptor response. Monoterpenes (α-pinene [22][23], linalool [24], borneol [25], linalool oxide [26], thymol [27], carvacrol [24], citronellol, and hinokitiol [22]), alcohol (1-octen-3-ol [24]), lactones (jasmine lactone and lactone derivatives [26]), esters (ethyl phenylpropanoate [28] and methyl jasmonate [26]), cyclic ketone (cis-jasmone [26]), and ethoxy [28] have all shown to potentiate a GABAA receptor response.
Studies using pharmacological agents that interact with the GABAergic system have shown that essential oils and their constituents have GABAergic involvement. Koo et al. [29] and Komori et al. [30] evaluated the influence essential oils inhalation may have on the GABAergic system via in vivo GABA transaminase assays and GABA activity. Results confirmed that exposure to A. gramineus and V. officinalis inhalation inhibited GABA transaminase and raised GABA levels, confirming the role these essential oils have on the GABAergic system. In addition, Soni et al. [31] reports in their review of the medical utility of lavender that lavender exerts a similar action to benzodiazepines and increases the effects of GABA in the amygdala, although more recent studies have confirmed that the serotonergic system is involved [32]. Flumazenil, a specific GABAA receptor antagonist, is used to determine anxiolytic-like occurring through the GABAergic system [33]. Co-administration of aristolen-1(10)-en-9-ol (from N. chinensis) and flumazenil, a specific GABAA receptor antagonist, or 1,8-cineole (present in L. Camara and E. globulus) and flumazenil reversed the effects of aristolen-1(10)-en-9-ol and 1,8-cineole implying an effect on GABAA-benzodiazepine receptors [34][35]. Terpinen-4-ol (present in compound anshen, Lavandula spp. and T. vulgaris) inhibiting 3-mercapto-propionic acid (3-MP), a glutamic acid decarboxylase inhibitor, induced convulsions demonstrating GABAergic involvement but did not reverse flumazenil confirming that terpinen-4-ol does not act on the same binding site as benzodiazepines [36].
Animal studies have used various behavioural modeling to assess anxiety and the involvement of the GABAergic system. The elevated plus maze is a widely used behavioural model that has predictive validity [37][38] that is specifically suited to evaluate anxiolytic substances that act via the GABAA-benzodiazepine receptor complex [39][40]. More than half of the animal studies examined in this research on essential oils used the elevated plus maze test. Despite variability in the inhalation duration of the essential oil, positive results were obtained in all elevated plus maze studies except for two. The first showed no anxiolytic effect from inhalation of I. verum; however, its main component, trans-anethole, did show anxiolytic effects [41]. The second showed an anxiogenic effect from a continual two-week exposure to C. limon essential oil vapour [42]. It is probable that chronic exposure to the essential oil was responsible for the anxiogenic effect, as Komiya et al. [43] demonstrated anxiolytic effects in an elevated plus maze from exposure to C. limon essential oil vapour for 90 min.
Of the clinical studies reviewed, there were a multitude of anxiety-related states where essential oil inhalation was applied, including pre- and post-operative anxiety, anticipation anxiety, during treatment anxiety, first-stage labour anxiety, and experimental and cognitive test anxiety. Orange [44][45], lavender [46][47], and eucalyptus [48] essential oils were used for preoperative anxiety; orange [49] and geranium [50] essential oils were used for post-operative anxiety and orange essential oil during treatment anxiety [51]; orange [52] and geranium [53] essential oils were used for first-stage labour anxiety; orange [51][54] and lemongrass [55] essential oils for experimental anxiety; and orange [56] essential oil for anticipation anxiety. There was considerable heterogeneity in the essential oil concentration, quantity applied, exposure time and mode of delivery. The concentration of the essential oil and quantity applied varied from 2–100% and 2–80 drops respectively with exposure time ranging from 3–35 min, or continual with majority of studies applied once per day, although one study was applied twice daily for three days. The mode of delivery ranged from electrical dispenser, nebuliser, to neutral support (cotton swab, medical patches, paper tissue, gauze, surgical mask, and aroma pads) with the latter making up the majority. Considering the heterogeneity of the available data from the clinical studies reviewed, further studies are warranted to confirm the application of essential oils delivered via inhalation for anxiety-related states.
In summary, many have explored and inferred anxiety-reducing effects via bio-behavioural animal studies, a few have alluded to compounds in the essential oils that interact with GABAergic transmission, and few have conducted elegant neuropharmacology studies to show a direct binding of the compound to the GABA receptor. Further studies are warranted to confirm that aromas, essential oils, and their constituents directly interact with the GABAA receptor complex.

References

  1. Wang, Z.J.; Heinbockel, T. Essential Oils and Their Constituents Targeting the Gabaergic System and Sodium Channels as Treatment of Neurological Diseases. Molecules 2018, 23, 1061.
  2. Nagappan, P.G.; Subramaniam, S.; Wang, D.Y. Olfaction as a Soldier—A Review of the Physiology and Its Present and Future Use in the Military. In Military Medical Research; BioMed Central Ltd.: London, UK, 2017.
  3. Lawless, J. The Encyclopedia of Essential Oils: The Complete Guide to the Use of Aromatic Oils in Aromatherapy, Herbalism, Health, and Well-Being; Conari Press: San Francisco, CA, USA, 2013.
  4. Sowndhararajan, K.; Kim, S. Influence of Fragrances on Human Psychophysiological Activity: With Special Reference to Human Electroencephalographic Response. Sci. Pharm. 2016, 84, 724–751.
  5. de Sousa, D.P.; de Almeida Soares Hocayen, P.; Andrade, L.N.; Andreatini, R. A Systematic Review of the Anxiolytic-like Effects of Essential Oils in Animal Models. Molecules 2015, 20, 18620–18660.
  6. Ghiasi, A.; Bagheri, L.; Haseli, A. A Systematic Review on the Anxiolytic Effect of Aromatherapy during the First Stage of Labor. J. Caring Sci. 2019, 8, 51–60.
  7. Krusemark, E.A.; Novak, L.R.; Gitelman, D.R.; Li, W. When the Sense of Smell Meets Emotion: Anxiety-State-Dependent Olfactory Processing and Neural Circuitry Adaptation. J. Neurosci. 2013, 33, 15324–15332.
  8. Nuss, P. Anxiety Disorders and GABA Neurotransmission: A Disturbance of Modulation. Neuropsychiatr. Dis. Treat. 2015, 11, 165–175.
  9. Forster, G.L.; Novick, A.M.; Scholl, J.L.; Watt, M.J. The Role of the Amygdala in Anxiety Disorders. Neuropsychiatr. Dis. Treat. 2015, 11, 165–175.
  10. Anand, K.S.; Dhikav, V. Review: Progress in Medicine (Update on Advances in Pathophysiology) Hippocampus in Health and Disease: An Overview. Annu. Indian Acad. Neurol. 2012, 15, 239–246.
  11. Cominski, T.P.; Jiao, X.; Catuzzi, J.E.; Stewart, A.L.; Pang, K.C.H. The Role of the Hippocampus in Avoidance Learning and Anxiety Vulnerability. Front. Behav. Neurosci. 2014, 8, 273.
  12. Jiménez-Balado, J.; Eich, T.S. GABAergic Dysfunction, Neural Network Hyperactivity and Memory Impairments in Human Aging and Alzheimer’s Disease. In Seminars in Cell and Developmental Biology; Elsevier Ltd.: Amsterdam, The Netherlands, 2021.
  13. Govindpani, K.; Guzmán, B.C.F.; Vinnakota, C.; Waldvogel, H.J.; Faull, R.L.; Kwakowsky, A. Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease. Int. J. Mol. Sci. 2017, 18, 1813.
  14. Lanctôt, K.L.; Herrmann, N.; Mazzotta, P.; Khan, L.R.; Ingber, N. GABAergic Function in Alzheimer’s Disease: Evidence for the Treatment of Behavioural and Psychological Symptoms of Dementia. Can. J. Psychiatry 2004, 49, 439–453.
  15. Sieghart, W. Structure, Pharmacology, and Function of GABAA Receptor Subtypes. Adv. Pharmacol. 2006, 54, 231–263.
  16. Scott, S.; Aricescu, A.R. A Structural Perspective on GABAA Receptor Pharmacology. Curr. Opin. Struct. Biol. 2019, 54, 189–197.
  17. Elgarf, A.A.; Siebert, D.C.B.; Steudle, F.; Draxler, A.; Li, G.; Huang, S.; Cook, J.M.; Ernst, M.; Scholze, P. Different Benzodiazepines Bind with Distinct Binding Modes to GABA A Receptors. ACS Chem. Biol. 2018, 13, 2033–2039.
  18. Zhong, Y.; Zheng, Q.; Hu, P.; Huang, X.; Yang, M.; Ren, G.; Du, Q.; Luo, J.; Zhang, K.; Li, J.; et al. Sedative and Hypnotic Effects of Compound Anshen Essential Oil Inhalation for Insomnia. BMC Complement. Altern. Med. 2019, 19, 306.
  19. Donelli, D.; Antonelli, M.; Bellinazzi, C.; Gensini, G.F.; Firenzuoli, F. Effects of Lavender on Anxiety: A Systematic Review and Meta-Analysis. Phytomedicine 2019, 65, 153099.
  20. Wang, S.; Wang, C.; Peng, D.; Liu, X.; Wu, C.; Guo, P.; Wei, J. Agarwood Essential Oil Displays Sedative-Hypnotic Effects through the GABAergic System. Molecules 2017, 22, 2190.
  21. Hossain, S.J.; Aoshima, H.; Koda, H.; Kiso, Y. Effects of Coffee Components on the Response of GABAA Receptors Expressed in Xenopus Oocytes. J. Agric. Food Chem. 2003, 51, 7568–7575.
  22. AOSHIMA, H.; HAMAMOTO, K. Potentiation of GABA A Receptors Expressed in Xenopus Oocytes by Perfume and Phytoncid. Biosci. Biotechnol. Biochem. 1999, 63, 743–748.
  23. Yang, H.; Woo, J.; Pae, A.N.; Um, M.Y.; Cho, N.C.; Park, K.D.; Yoon, M.; Kim, J.; Lee, C.J.; Cho, S. α-Pinene, a Major Constituent of Pine Tree Oils, Enhances Non-Rapid Eye Movement Sleep in Mice through GABAA-Benzodiazepine Receptors. Mol. Pharmacol. 2016, 90, 530–539.
  24. Kessler, A.; Sahin-Nadeem, H.; Lummis, S.C.R.; Weigel, I.; Pischetsrieder, M.; Buettner, A.; Villmann, C. GABAA Receptor Modulation by Terpenoids from Sideritis Extracts. Mol. Nutr. Food Res. 2014, 58, 851–862.
  25. Granger, R.E.; Campbell, E.L.; Johnston, G.A.R. (+)- And (-)-Borneol: Efficacious Positive Modulators of GABA Action at Human Recombinant A1β2γ2L GABAA Receptors. Biochem. Pharmacol. 2005, 69, 1101–1111.
  26. Hossain, S.J.; Aoshima, H.; Koda, H.; Kiso, Y. Fragrances in Oolong Tea That Enhance the Response of GABAA Receptors. Biosci. Biotechnol. Biochem. 2004, 68, 1842–1848.
  27. Priestley, C.M.; Williamson, E.M.; Wafford, K.A.; Sattelle, D.B. Thymol, a Constituent of Thyme Essential Oil, Is a Positive Allosteric Modulator of Human GABA A Receptors and a Homo-Oligomeric GABA Receptor from Drosophila Melanogaster. Br. J. Pharmacol. 2003, 140, 1363–1372.
  28. Hossain, S.J.; Aoshima, H.; Koda, H.; Kiso, Y. Potentiation of the Ionotropic GABA Receptor Response by Whiskey Fragrance. J. Agric. Food Chem. 2002, 50, 6828–6834.
  29. Koo, B.S.; Park, K.S.; Ha, J.H.; Park, J.H.; Lim, J.C.; Lee, D.U. Inhibitory Effects of the Fragrance Inhalation of Essential Oil from Acorus gramineus on Central Nervous System. Biol. Pharm. Bull. 2003, 26, 978–982.
  30. Komori, T.; Matsumoto, T.; Motomura, E.; Shiroyama, T. The Sleep-Enhancing Effect of Valerian Inhalation and Sleep-Shortening Effect of Lemon Inhalation. Chem. Senses 2006, 31, 731–737.
  31. Soni, R.P.; Katoch, M.; Rana, S.S.; Kumar, A. An Overview of the Medical Utility of Lavender. Himachal J. Agric. Res. 2016, 42, 1–8.
  32. Chioca, L.R.; Ferro, M.M.; Baretta, I.P.; Oliveira, S.M.; Silva, C.R.; Ferreira, J.; Losso, E.M.; Andreatini, R. Anxiolytic-like Effect of Lavender Essential Oil Inhalation in Mice: Participation of Serotonergic but Not GABAA/Benzodiazepine Neurotransmission. J. Ethnopharmacol. 2013, 147, 412–418.
  33. Costa, C.A.R.D.A.; Kohn, D.O.; De Lima, V.M.; Gargano, A.C.; Flório, J.C.; Costa, M. The GABAergic System Contributes to the Anxiolytic-like Effect of Essential Oil from Cymbopogon citratus (Lemongrass). J. Ethnopharmacol. 2011, 137, 828–836.
  34. Takemoto, H.; Ito, M.; Asada, Y.; Kobayashi, Y. Inhalation Administration of the Sesquiterpenoid Aristolen-1(10)-En-9-Ol from Nardostachys chinensis Has a Sedative Effect via the Gabaergic System. Planta Med. 2015, 81, 343–347.
  35. Dougnon, G.; Ito, M. Inhalation Administration of the Bicyclic Ethers 1,8- And 1,4-Cineole Prevent Anxiety and Depressive-like Behaviours in Mice. Molecules 2020, 25, 1884.
  36. Nóbrega, F.F.F.; Salvadori, M.G.S.S.; Masson, C.J.; Mello, C.F.; Nascimento, T.S.; Leal-Cardoso, J.H.; De Sousa, D.P.; Almeida, R.N. Monoterpenoid Terpinen-4-Ol Exhibits Anticonvulsant Activity in Behavioural and Electrophysiological Studies. Oxid. Med. Cell. Longev. 2014, 2014, 703848.
  37. McLachlan, C.S.; Yi Xing Soh, C. Differences in Anxiety-Related Behavior between Apolipoprotein E-Deficient C57BL/6 and Wild Type C57BL/6 Mice. Physiol. Res. 2005, 54, 701–704.
  38. Walf, A.A.; Frye, C.A. The Use of the Elevated plus Maze as an Assay of Anxiety-Related Behavior in Rodents. Nat. Protoc. 2007, 2, 322–328.
  39. Pellow, S.; File, S.E. Anxiolytic and Anxiogenic Drug Effects on Exploratory Activity in an Elevated Plus-Maze: A Novel Test of Anxiety in the Rat. Pharmacol. Biochem. Behav. 1986, 24, 525–529.
  40. Rodgers, R.J.; Dalvi, A. Anxiety, Defence and the Elevated plus-Maze. Neurosci. Biobehav. Rev. 1997, 21, 801–810.
  41. Miyagawa, M.; Satou, T.; Yukimune, C.; Ishibashi, A.; Seimiya, H.; Yamada, H.; Hasegawa, T.; Koike, K. Anxiolytic-like Effect of Illicium Verum Fruit Oil, Trans-Anethole and Related Compounds in Mice. Phyther. Res. 2014, 28, 1710–1712.
  42. Ceccarelli, I.; Lariviere, W.R.; Fiorenzani, P.; Sacerdote, P.; Aloisi, A.M. Effects of Long-Term Exposure of Lemon Essential Oil Odor on Behavioral, Hormonal and Neuronal Parameters in Male and Female Rats. Brain Res. 2004, 1001, 78–86.
  43. Komiya, M.; Takeuchi, T.; Harada, E. Lemon Oil Vapor Causes an Anti-Stress Effect via Modulating the 5-HT and DA Activities in Mice. Behav. Brain Res. 2006, 172, 240–249.
  44. Hasheminia, D.; Kalantar Motamedi, M.R.; Karimi Ahmadabadi, F.; Hashemzehi, H.; Haghighat, A. Can Ambient Orange Fragrance Reduce Patient Anxiety during Surgical Removal of Impacted Mandibular Third Molars? J. Oral Maxillofac. Surg. 2014, 72, 1671–1676.
  45. Pimenta, F.C.F.; Alves, M.F.; Pimenta, M.B.F.; Melo, S.A.L.; De Almeida, A.A.F.; Leite, J.R.; Pordeus, L.C.D.M.; Diniz, M.D.F.F.M.; De Almeida, R.N. Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia. Phyther. Res. 2016, 30, 613–617.
  46. Yayla, E.M.; Ozdemir, L. Effect of Inhalation Aromatherapy on Procedural Pain and Anxiety after Needle Insertion into an Implantable Central Venous Port Catheter: A Quasi-Randomized Controlled Pilot Study. Cancer Nurs. 2019, 42, 35–41.
  47. Arslan, I.; Aydinoglu, S.; Karan, N.B. Can Lavender Oil Inhalation Help to Overcome Dental Anxiety and Pain in Children? A Randomized Clinical Trial. Eur. J. Pediatr. 2020, 179, 985–992.
  48. Kim, K.Y.; Seo, H.J.; Min, S.S.; Park, M.; Seol, G.H. The Effect of 1,8-Cineole Inhalation on Preoperative Anxiety: A Randomized Clinical Trial. Evid.-Based Complement. Altern. Med. 2014, 2014, 820126.
  49. Moslemi, F.; Alijaniha, F.; Naseri, M.; Kazemnejad, A.; Charkhkar, M.; Heidari, M.R. Citrus aurantium Aroma for Anxiety in Patients with Acute Coronary Syndrome: A Double-Blind Placebo-Controlled Trial. J. Altern. Complement. Med. 2019, 25, 833–839.
  50. Shirzadegan, R.; Gholami, M.; Hasanvand, S.; Birjandi, M.; Beiranvand, A. Effects of Geranium Aroma on Anxiety among Patients with Acute Myocardial Infarction: A Triple-Blind Randomized Clinical Trial. Complement. Ther. Clin. Pract. 2017, 29, 201–206.
  51. Pour, F.; Arman, S.; Jaafarzadeh, M. Effect of Aromatherapy with Orange Essential Oil on Salivary Cortisol and Pulse Rate in Children during Dental Treatment: A Randomized Controlled Clinical Trial. Adv. Biomed. Res. 2013, 2, 10.
  52. Namazi, M.; Amir Ali Akbari, S.; Mojab, F.; Talebi, A.; Alavi Majd, H.; Jannesari, S. Aromatherapy with Citrus aurantium Oil and Anxiety during the First Stage of Labor. Iran. Red Crescent Med. J. 2014, 16, e18371.
  53. Rashidi Fakari, F.; Tabatabaeichehr, M.; Kamali, H.; Rashidi Fakari, F.; Naseri, M. Effect of Inhalation of Aroma of Geranium Essence on Anxiety and Physiological Parameters during First Stage of Labor in Nulliparous Women: A Randomized Clinical Trial. J. Caring Sci. 2015, 4, 135–141.
  54. Chaves Neto, G.; Braga, J.E.F.; Alves, M.F.; De Morais Pordeus, L.C.; Dos Santos, S.G.; Scotti, M.T.; Almeida, R.N.; Diniz, M.D.F.F.M. Anxiolytic Effect of Citrus aurantium L. in Crack Users. Evid.-Based Complement. Altern. Med. 2017, 2017, 7217619.
  55. Goes, T.C.; Ursulino, F.R.C.; Almeida-Souza, T.H.; Alves, P.B.; Teixeira-Silva, F. Effect of Lemongrass Aroma on Experimental Anxiety in Humans. J. Altern. Complement. Med. 2015, 21, 766–773.
  56. Lehrner, J.; Eckersberger, C.; Walla, P.; Pötsch, G.; Deecke, L. Ambient Odor of Orange in a Dental Office Reduces Anxiety and Improves Mood in Female Patients. Physiol. Behav. 2000, 71, 83–86.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Integrative & Complementary Medicine
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Neville Hartley
,
Craig McLachlan
View Times: 1.2K
Revisions: 2 times (View History)
Update Date: 19 Apr 2022
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback